BRL-3A Cells

Unit

3 x 10^6 cells/ml

Cell Type

Immortalized Cells

Tissue Type

Rat cell lines

Organism

Rat

Donor History
Growth Properties

Adherent

Growth Conditions

Culture medium: Ham's F12

,

w: 1.0 mM stable Glutamine

,

w: 1.0 mM Sodium pyruvate

,

w: 1.1 g/L NaHCO3 (Cytion article number 820600a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Seeding density: Seeding density of 1 x 10⁴ cells/cm² is recommended. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/BRL-3A-Cells/500129

SKU: 500129 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The BRL-3A cell line is derived from the normal liver of a male Buffalo rat. Established in 1976, this cell line is an important in vitro model primarily used for studying hepatocyte function, liver regeneration mechanisms, and hepatotoxicity. BRL-3A cells retain several characteristics of primary hepatocytes, including the ability to synthesize albumin and other serum proteins, making them a valuable tool in hepatological research. These cells exhibit an epithelial-like morphology and are adherent with a high growth rate in culture.

Scientific interest in BRL-3A extends to its application in the study of liver-specific viral infections, drug metabolism, and the effects of various growth factors and cytokines on liver cells. Researchers also utilize BRL-3A cells to investigate the impact of toxins and carcinogens on liver function, providing insights into hepatocarcinogenesis and liver injury. The cells are known to respond to peroxisome proliferators and have been used to test the efficacy and safety of pharmaceuticals potentially affecting liver function.

However, despite their versatility, users of the BRL-3A cell line must consider the limitations inherent to a non-human model, as results may not always directly translate to human liver physiology. This factor underscores the importance of corroborating findings with additional models and experimental approaches.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.